Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sézary syndrome

被引:0
|
作者
Kenta Oka
Takuya Miyagawa
Hiraku Suga
Tomomitsu Miyagaki
Yuka Mizuno
Hiroaki Kamijo
Teruyoshi Hisamoto
Issei Omori
Hikari Boki
Tomonori Oka
Naomi Takahashi-Shishido
Makoto Sugaya
Shinichi Sato
机构
[1] University of Tokyo Graduate School of Medicine,Department of Dermatology
[2] St. Marianna University School of Medicine,Department of Dermatology
[3] International University of Health and Welfare,Department of Dermatology
来源
关键词
atopic dermatitis; cutaneous T-cell lymphoma; mycosis fungoides; Sézary syndrome; squamous cell carcinoma antigen;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:464 / 470
页数:6
相关论文
共 50 条
  • [31] Perspectives on and Quality of Life in Skin of Color Patients With Mycosis Fungoides/S?zary Syndrome: A Qualitative Analysis
    Abraham, Jaclyn
    Wei, Grace
    Desai, Seemal R.
    Chen, Pei-Ling
    Seminario-Vidal, Lucia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [32] What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
    Akilov, Oleg E.
    CELLS, 2023, 12 (18)
  • [33] Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
    Alessandro Pileri
    Cinzia Pellegrini
    Claudio Agostinelli
    Vieri Grandi
    Annalisa Patrizi
    Pier Luigi Zinzani
    Nicola Pimpinelli
    European Journal of Dermatology, 2017, 27 : 49 - 53
  • [34] Programmed death 1 expression in mycosis fungoides and Sezary syndrome
    Wada, David
    Comfere, Nneka
    Harrington, Susan
    Ryan, Wilcox
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB114 - AB114
  • [35] Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment
    Fujii, Kazuyasu
    Yoshizaki, Ai
    Matsuoka, Atsuko
    Baba, Naoko
    Ohshima, Koichi
    Kanekura, Takuro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (03) : 294 - 296
  • [36] Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients
    Gandham, Ashley R.
    Geller, Shamir
    Dusza, Stephen W.
    Kupper, Thomas S.
    Myskowski, Patricia. L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e174 - e180
  • [37] Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sézary syndrome: never-late, never-never?
    H. Miles Prince
    Chathuri Abeyakoon
    Bone Marrow Transplantation, 2021, 56 : 1232 - 1234
  • [38] The interferon story continues: EORTC CLTG study explores pegylated interferon α-2a's role in treating mycosis fungoides/Sézary syndrome
    Stadler, Rudolf
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 321 - 322
  • [39] Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study
    Belfrage, Emma
    Sara, E. K.
    Johansson, Asa
    Brauner, Hanna
    Sonesson, Andreas
    Drott, Kristina
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [40] The efficacy and safety of extracorporeal photopheresis (ECP) for treatment of mycosis fungoides and/or se′zary syndrome in cutaneous T-cell lymphoma
    Stone, V.
    Mesa, O. A.
    Covassin, L.
    McCloskey, C.
    Chuang, L. H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S81 - S81